Literature DB >> 2251950

Exaggerated spontaneous release of tumor necrosis factor-alpha/cachectin in patients with migraine without aura.

V Covelli1, I Munno, N M Pellegrino, A Di Venere, E Jirillo, G A Buscaino.   

Abstract

Serum levels of tumor necrosis factor (TNF)-alpha/cachectin have been evaluated in 20 patients with Migraine without Aura (MwA) versus 17 patients with Chronic Type Tension Headache (CTTH). Results show an exaggerated release of TNF-alpha/cachectin in sera of patients affected by MwA, while in CTTH patients TNF serum concentration is comparable to that observed in normal donors. Some hypotheses are formulated in order to clarify the TNF-alpha/cachectin spontaneous production and its biological significance in patients with MwA.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2251950

Source DB:  PubMed          Journal:  Acta Neurol (Napoli)        ISSN： 0001-6276


  11 in total

Review 1.  Tumour necrosis factor gene polymorphisms and migraine: a systematic review and meta-analysis.

Authors:  Markus Schürks; Pamela M Rist; Robert Yl Zee; Daniel I Chasman; Tobias Kurth
Journal:  Cephalalgia       Date:  2011-10       Impact factor: 6.292

2.  The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura.

Authors:  Shahir Mazaheri; Mehrdad Hajilooi; Alireza Rafiei
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

3.  Hypothalamic involvement in chronic migraine.

Authors:  M F Peres; M Sanchez del Rio; M L Seabra; S Tufik; J Abucham; J Cipolla-Neto; S D Silberstein; E Zukerman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

4.  The serum level of inflammatory markers in chronic and episodic migraine: a case-control study.

Authors:  Fahimeh Martami; Soodeh Razeghi Jahromi; Mansoureh Togha; Zeinab Ghorbani; Maryam Seifishahpar; Atoosa Saidpour
Journal:  Neurol Sci       Date:  2018-07-15       Impact factor: 3.307

5.  A candidate gene association study of 77 polymorphisms in migraine.

Authors:  Markus Schürks; Tobias Kurth; Julie E Buring; Robert Y L Zee
Journal:  J Pain       Date:  2009-07       Impact factor: 5.820

6.  Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients.

Authors:  Javier Trigo; David García-Azorín; Álvaro Sierra-Mencía; Álvaro Tamayo-Velasco; Pedro Martínez-Paz; Eduardo Tamayo; Angel Luis Guerrero; Hugo Gonzalo-Benito
Journal:  J Headache Pain       Date:  2021-06-04       Impact factor: 7.277

Review 7.  Genetics of migraine in the age of genome-wide association studies.

Authors:  Markus Schürks
Journal:  J Headache Pain       Date:  2011-11-11       Impact factor: 7.277

8.  Increased Serum CD14 Level Is Associated with Depletion of TNF-α in Monocytes in Migraine Patients during Interictal Period.

Authors:  Slawomir Michalak; Alicja Kalinowska-Lyszczarz; Danuta Wegrzyn; Adam Niezgoda; Jacek Losy; Krystyna Osztynowicz; Wojciech Kozubski
Journal:  Int J Mol Sci       Date:  2017-02-13       Impact factor: 5.923

9.  Introducing Genes With Significant Role in Migraine: An Interactomic Approach.

Authors:  Mona Zamanian Azodi; Mostafa Rezaei Tavirani; Reza Mahmoud Robati
Journal:  Basic Clin Neurosci       Date:  2019-07-01

10.  Protective effect of puerarin against burn-induced heart injury in rats.

Authors:  Junling Liu; Jianyun Liu; Mingming Bai; Hui Wang
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.